1 active not recruiting, 1 recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Active not recruiting 1, Recruiting 1 |
Follow Joseph Broderick, MD: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2 Recombinant Factor VIIa, Biological/Vaccine: Placebo - Intracerebral Hemorrhage | Phase 3 | Recruiting | Joseph Broderick, MD | 350 | 2025-05-06 | 2026-08-20 |
| Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial Recombinant Activated Factor VII (rFVIIa), Placebo - Intracerebral Hemorrhage | Phase 3 | Active not recruiting | Joseph Broderick, MD | 860 | 2021-12-03 | 2026-01-21 |
recombinant FVIIa (2) · Biological Products (1)
Canada (2) · Germany (2) · Japan (2) · Spain (2) · United Kingdom (2) · United States (2)
PMID 34427473, PMID 37870112, PMID 39654449, PMID 41653933
U01NS110772 (2), 2019 (1)